| 发明名称 |
7-Methyl-2-[4-methyl-6-[4-(trifluoromethyl)-phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]nonan-6-one |
| 摘要 |
The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation. |
| 申请公布号 |
EP2861602(B1) |
申请公布日期 |
2016.08.10 |
| 申请号 |
EP20130725438 |
申请日期 |
2013.05.22 |
| 申请人 |
CONVERGENCE PHARMACEUTICALS LIMITED |
发明人 |
GIBLIN, GERARD M P;MACPHERSON, DAVID T;WITTY, DAVID R;STANWAY, STEVEN J |
| 分类号 |
C07D487/10;A61K31/407;A61P25/00 |
主分类号 |
C07D487/10 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
